[What's new in neuropharmacology?].
Castrén
E
E
Kuopion yliopisto A. I. Virtanen -instituutti PL 1627, 70211 Kuopio. eero.castren@uku.fi
Männistö
P T
PT
Tiihonen
J
J
D000437:Alcoholism / Q000188:drug therapy; D000544:Alzheimer Disease / Q000188:drug therapy; D000818:Animals; D002394:Catechol O-Methyltransferase / Q000378:metabolism; D065098:Catechol O-Methyltransferase Inhibitors; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy; D015316:Genetic Therapy; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D009480:Neuropharmacology / Q000639:trends*; D018696:Neuroprotective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000628:therapy; D011618:Psychotic Disorders / Q000188:drug therapy
D065098:Catechol O-Methyltransferase Inhibitors; D008996:Monoamine Oxidase Inhibitors; D018696:Neuroprotective Agents; D002394:Catechol O-Methyltransferase
Mitä uutta neurofarmakologiasta?